Article
Ozempic Is About to Go Generic in India, China and Canada
Bearish
-71.4
−100 Bearish
0
+100 Bullish
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
New York Times Business
Published
Mar 19, 2026 · 4:00 am
Article ID
371jsbe
Original URL
Open source
Sentiment Signal
Bearish
-71.4
−100Neutral+100
More Like This